share_log

醫渡科技：截至二零二三年十二月三十日止股份發行人的證券變動月報表

YIDU TECH: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 5 05:36
Summary by Moomoo AI
医渡科技有限公司於2024年1月5日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，總額為50,000美元，普通股股份數目為2,500,000,000股。在股份期權方面，根據公司的股份期權計劃，首次公開發售後購股權計劃及首次公開發售前購股權計劃1和2中，有部分股份期權已行使或失效，導致股份期權數目有所變動。本月內因行使期權所得資金總額為22,150.1港元。此外，公司亦根據經修訂的首次公開發售後股份獎勵計劃發行了46,245股新股份。總計本月普通股增加了140,710股。報告中亦確認，所有證券發行均已獲得董事會授權並符合相關上市規則。
医渡科技有限公司於2024年1月5日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，總額為50,000美元，普通股股份數目為2,500,000,000股。在股份期權方面，根據公司的股份期權計劃，首次公開發售後購股權計劃及首次公開發售前購股權計劃1和2中，有部分股份期權已行使或失效，導致股份期權數目有所變動。本月內因行使期權所得資金總額為22,150.1港元。此外，公司亦根據經修訂的首次公開發售後股份獎勵計劃發行了46,245股新股份。總計本月普通股增加了140,710股。報告中亦確認，所有證券發行均已獲得董事會授權並符合相關上市規則。
Medical Technology Limited filed with Hong Kong Trading and Settlement Limited on 5 January 2024 with Hong Kong Trading and Settlement Limited its Monthly Securities Change Report for the year ended 31 December 2023. The report showed that the company's regulary/registered share capital remained unchanged, totaling $50,000 and the number of ordinary shares was 2,500,000,000 shares. In terms of stock options, some share options have been exercised or invalidated under the Company's Share Option Scheme, Initial Public Offering Option Scheme and Initial Public Offering Option Plans 1 and 2, which has caused a change in the number of share options. The total amount of capital received from the exercise of options during the month was HK$22,150.1. In addition, the Company also issued 46,245 new shares under the revised Initial Public Offering Post-IPO Share Award Scheme. In total, ordinary shares increased by 140,710 shares this month. The report also confirms that all securities issuances have been authorized by the Board of Directors and comply with the relevant listing rules.
Medical Technology Limited filed with Hong Kong Trading and Settlement Limited on 5 January 2024 with Hong Kong Trading and Settlement Limited its Monthly Securities Change Report for the year ended 31 December 2023. The report showed that the company's regulary/registered share capital remained unchanged, totaling $50,000 and the number of ordinary shares was 2,500,000,000 shares. In terms of stock options, some share options have been exercised or invalidated under the Company's Share Option Scheme, Initial Public Offering Option Scheme and Initial Public Offering Option Plans 1 and 2, which has caused a change in the number of share options. The total amount of capital received from the exercise of options during the month was HK$22,150.1. In addition, the Company also issued 46,245 new shares under the revised Initial Public Offering Post-IPO Share Award Scheme. In total, ordinary shares increased by 140,710 shares this month. The report also confirms that all securities issuances have been authorized by the Board of Directors and comply with the relevant listing rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more